AIM Vaccine Market Cap

AIM Vaccine has a market cap or net worth of 8.47 billion as of November 15, 2024. Its market cap has decreased by -28.31% in one year.

Market Cap

8.47B

Enterprise Value

10.13B

Revenue

1.27B

Ranking

n/a

PE Ratio

n/a

Stock Price

7.50

Market Cap Chart

Since October 6, 2022, AIM Vaccine's market cap has decreased from 20.15B to 8.47B, a decrease of -58.00%. That is a compound annual growth rate of -33.71%.

Market Cap History

Date	Market Cap	% Change
Nov 14, 2024	8.54B	-10.19%
Dec 29, 2023	9.51B	-67.02%
Dec 30, 2022	28.82B	43.02%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition